HIV-Specific T Cell Responses in Rectal Mucosa
直肠粘膜中 HIV 特异性 T 细胞反应
基本信息
- 批准号:8668880
- 负责人:
- 金额:$ 62.95万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2003
- 资助国家:美国
- 起止时间:2003-07-11 至 2017-05-31
- 项目状态:已结题
- 来源:
- 关键词:AIDS/HIV problemAcuteAddressAffectApoptosisBiological MarkersBiopsyBloodCD4 Positive T LymphocytesCD8B1 geneCell physiologyCellsChronicClinicalContainmentCytoplasmic GranulesDendritic CellsDiagnosisDiseaseEnrollmentEnvironmentEpigenetic ProcessEpithelialEquilibriumGastrointestinal tract structureGoalsHIVHIV InfectionsHIV SeropositivityHighly Active Antiretroviral TherapyHost DefenseHousingImmuneImmune ToleranceImmune responseImmunologic MarkersIndividualInfectionInstitutional Review BoardsLamina PropriaLeadLeukocytesLicensingLymphoidMediatingMessenger RNAMucosal Immune ResponsesMucous MembraneOrganOutcomePatientsPersonsPhenotypePlasmaProteinsProtocols documentationRegulationResearch DesignRoleSIVSamplingSeminalSiteT cell responseT-LymphocyteTestingTissuesVaccine DesignViralViral Load resultVirusWorkchemokinecohortcommensal microbescytokinecytotoxiccytotoxicityexhaustexhaustionfightingfood antigengastrointestinalimmune activationkiller T cellmicrobialpathogenperforinpreventpublic health relevancereconstitutionrectalresearch studyresponsetransmission process
项目摘要
DESCRIPTION (provided by applicant): The overall goal of this proposal is to elucidate the role of HIV-specific CD8 T-cells in the gastrointestinal mucosa in controlling viral replication an dissemination. The gastrointestinal (GI) mucosa is a major site of HIV transmission, a critical early site of viral replication and CD4 depletion, as well as the largest lymphoid organ in the body. Accordingly, host defenses in this tissue may be critical in determining clinical outcome. The GI tract is also a unique mucosal tissue with innate and adaptive defenses that are carefully regulated to maintain a delicate balance between immune tolerance to commensal bacteria and food antigens versus the ability to mount rapid immune responses to pathogens. During acute HIV/SIV infection, as lamina propria CD4 T-cells are depleted, there is an expansion and/or influx of CD8 T-cells; however, these cells fail to clear infection or prevent widespread virus dissemination. This rapid depletion of gut CD4 T-cells, and their slow reconstitution in patients on HAART, suggests that mucosal CD8 T-cell responses are inadequate or dysfunctional in most individuals. In Specific Aim 1, we will test the hypothesis that tissue- specific mechanisms, including transcriptional and/or epigenetic regulation, limit perforin-mediated CD8 T-cell effector
functions in the gastrointestinal mucosa. In Specific Aim 2, we will focus on mucosal T-cell responses in individuals diagnosed with acute/early HIV infection, generally less than 30 days post-seroconversion. We will test the hypotheses that (a) robust mucosal CD8 T-cell responses during early infection are predictive of low viral load set-point; and (b) HAART initiation during early infection will lead to blunted mucosal CD8 T-cell responses, but may preserve mucosal integrity. In Specific Aim 3, we will study mucosal T-cell responses in patients with chronic HIV infection at opposite ends of the clinical spectrum: HIV controllers, with VL <2,000 copies/mL in the absence of HAART, and non-controllers, with VL >10,000 copies/mL in the absence of HAART. We will test the prediction that mucosal CD8 T-cells in HIV Controllers strongly express perforin and other cytotoxic granule constituents, while mucosal CD8 T-cells in HIV non-controllers display an 'exhausted' phenotype that may be partially reversed by HAART. These studies address important unanswered questions regarding the regulation of mucosal immune responses, which are of particular significance for the design of vaccine approaches aimed at induction of mucosal CD8 T-cell responses.
描述(由申请人提供):本提案的总体目标是阐明胃肠道粘膜中HIV特异性CD 8 T细胞在控制病毒复制和传播中的作用。胃肠道(GI)粘膜是HIV传播的主要部位,是病毒复制和CD 4耗竭的关键早期部位,也是体内最大的淋巴器官。因此,在这种组织中的宿主防御可能是决定临床结果的关键。胃肠道也是一种独特的粘膜组织,具有先天性和适应性防御,其被仔细调节以维持对肠道细菌和食物抗原的免疫耐受性与对病原体产生快速免疫应答的能力之间的微妙平衡。在急性HIV/SIV感染期间,由于固有层CD 4 T细胞耗尽,存在CD 8 T细胞的扩增和/或流入;然而,这些细胞不能清除感染或防止广泛的病毒传播。这种肠道CD 4 T细胞的快速消耗及其在HAART患者中的缓慢重建表明,大多数个体中粘膜CD 8 T细胞应答不足或功能失调。在具体目标1中,我们将检验组织特异性机制(包括转录和/或表观遗传调节)限制穿孔素介导的CD 8 T细胞效应子表达的假设。
在胃肠道粘膜中起作用。在具体目标2中,我们将重点关注被诊断为急性/早期HIV感染的个体的粘膜T细胞反应,通常在血清转换后不到30天。我们将检验以下假设:(a)早期感染期间强粘膜CD 8 T细胞应答预测低病毒载量设定点;(B)早期感染期间开始HAART治疗将导致粘膜CD 8 T细胞应答减弱,但可能保持粘膜完整性。在具体目标3中,我们将研究慢性HIV感染患者的粘膜T细胞反应,这些患者处于临床谱的两端:HIV控制者,在没有HAART的情况下VL <2,000拷贝/mL,以及非控制者,在没有HAART的情况下VL > 10,000拷贝/mL。我们将测试的预测,粘膜CD 8 T细胞在HIV控制器强烈表达穿孔素和其他细胞毒性颗粒成分,而粘膜CD 8 T细胞在HIV非控制器显示一个'耗尽'的表型,可以部分逆转HAART。这些研究解决了关于粘膜免疫应答的调节的重要的未回答的问题,这对于旨在诱导粘膜CD 8 T细胞应答的疫苗方法的设计具有特别重要的意义。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Barbara L. Shacklett其他文献
Increases in HIV Incidence Following Receptive Anal Intercourse Among Women: A Systematic Review and Meta-analysis
- DOI:
10.1007/s10461-019-02651-0 - 发表时间:
2019-09-04 - 期刊:
- 影响因子:2.400
- 作者:
James Stannah;Romain Silhol;Jocelyn Elmes;Branwen Owen;Barbara L. Shacklett;Peter Anton;Ian McGowan;Ariane van der Straten;Dobromir Dimitrov;Rebecca F. Baggaley;Marie-Claude Boily - 通讯作者:
Marie-Claude Boily
Barbara L. Shacklett的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Barbara L. Shacklett', 18)}}的其他基金
UC Davis Shared Astrios Cell Sorter
加州大学戴维斯分校共享 Astrios 细胞分选机
- 批准号:
8826347 - 财政年份:2015
- 资助金额:
$ 62.95万 - 项目类别:
HIV-Specific T Cell Responses in Rectal Mucosa
直肠粘膜中 HIV 特异性 T 细胞反应
- 批准号:
8077555 - 财政年份:2010
- 资助金额:
$ 62.95万 - 项目类别:
CNS Immune/Inflammatory Biomarkers in HIV Controllers
HIV 控制者的中枢神经系统免疫/炎症生物标志物
- 批准号:
7939616 - 财政年份:2009
- 资助金额:
$ 62.95万 - 项目类别:
Immunopathogenesis of HIV in the Female Reproductive Tract
女性生殖道中艾滋病毒的免疫发病机制
- 批准号:
7684933 - 财政年份:2009
- 资助金额:
$ 62.95万 - 项目类别:
Frequency and Function of HIV-specific T-cells in GALT
GALT 中 HIV 特异性 T 细胞的频率和功能
- 批准号:
6589886 - 财政年份:2003
- 资助金额:
$ 62.95万 - 项目类别:
HIV-Specific T Cell Responses in Rectal Mucosa
直肠粘膜中 HIV 特异性 T 细胞反应
- 批准号:
7755799 - 财政年份:2003
- 资助金额:
$ 62.95万 - 项目类别:
Cell-mediated immune responses to HIV-1 in GALT
GALT 中细胞介导的针对 HIV-1 的免疫反应
- 批准号:
6775648 - 财政年份:2003
- 资助金额:
$ 62.95万 - 项目类别:
HIV-Specific T Cell Responses in Rectal Mucosa
直肠粘膜中 HIV 特异性 T 细胞反应
- 批准号:
7418720 - 财政年份:2003
- 资助金额:
$ 62.95万 - 项目类别:
HIV-Specific T Cell Responses in Rectal Mucosa
直肠粘膜中 HIV 特异性 T 细胞反应
- 批准号:
8210992 - 财政年份:2003
- 资助金额:
$ 62.95万 - 项目类别:
Cell-mediated immune responses to HIV-1 in GALT
GALT 中细胞介导的针对 HIV-1 的免疫反应
- 批准号:
6982786 - 财政年份:2003
- 资助金额:
$ 62.95万 - 项目类别:
相似海外基金
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 62.95万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 62.95万 - 项目类别:
Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 62.95万 - 项目类别:
Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 62.95万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 62.95万 - 项目类别:
Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 62.95万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 62.95万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 62.95万 - 项目类别:
Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 62.95万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
- 批准号:
484000 - 财政年份:2023
- 资助金额:
$ 62.95万 - 项目类别:
Operating Grants